Perfecseal's high-barrier PVC-free blister-forming web, PerfecForm SkyBlue, is based on polyolefin chemistry, and its new high-barrier flow-wrap specification, PerfecPharm P232, is capable of achieving hermetic seals at the maximum speed capabilities of the top flow-wrap equipment.
Perfecseal has introduced a new high-barrier, PVC-free, blister-forming web, PerfecForm SkyBlue, designed to be cost effective and provide barrier properties to protect all but the highest barrier requirement product applications. This high-barrier blister film is based on polyolefin chemistry, rather than the chlorine chemistry used to produce PVC forming webs.
Unlike other barrier blister films, PerfecForm SkyBlue is manufactured via a co-extrusion process as a symmetrical structure. The thickness of the barrier layer, which is sandwiched between co-polyester, determines the overall barrier performance.
Perfecseal has also introduced a new high-barrier flow-wrap specification, PerfecPharm P232, which is capable of achieving hermetic seals at the maximum speed capabilities of the top flow-wrap equipment. “Perfecseal evaluated this product on high-speed Bosch flow-wrap equipment to assure this product would meet the desired performance level demanded by the healthcare market,” states Georgia Mohr, pharmaceutical director of Perfecseal, in a press release. “The P232 flow wrap material offers a large sealing window (140°C–200°C) and the potential to run at lower temperatures than traditional materials, yet seals hermetically at speeds exceeding 300 ppm.” Once again, Perfecseal delivers packaging solutions based on material science expertise.
Perfecseal, a division of Bemis Company, specializes in healthcare packaging and delivers packaging solutions based on material science expertise.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.